巴西专利BR112012029642B1 DRUG ADMINISTRATION DEVICE

专利PDF首页>>巴西专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
drug delivery device. the present invention provides a drug delivery device (10) for the injection of a drug, the device of which includes: a tubular reservoir (14) for accommodating a drug; a stopper (44) slidably arranged in the reservoir; a spring (58) for moving the stopper from a first position to a second position in the reservoir; at least one needle (16), the needle having a distal end (46) for insertion into a patient, and a lumen (48) extending proximally from the distal end, the lumen being in direct or indirect communication with the reservoir ; a needle driver (18) for moving the needle from a first state to a second state; and an actuator (20). activation of the actuator causes the spring to move the cork from the first position to the second position, and the needle driver to move the needle from the first state to the second state. the needle moves with respect to, and separately from, the reservoir, with the needle being moved from the first state to the second state. advantageously, with the present invention, a drug delivery device is provided, in which a needle moves with respect to the reservoir when being moved for injection. this allows the control to control the displacement of the needle separately from the reservoir.
公开号:BR112012029642B1
申请号:R112012029642-6
申请日:2011-03-28
公开日:2020-05-26
发明作者:Richard A. Cronenberg；Lionel Vedrine；Paul Alchas
申请人:Becton, Dickinson And Company；
IPC主号:

专利说明:

DRUG ADMINISTRATION DEVICE
FIELD OF THE INVENTION
[001] The present invention relates to drug delivery devices for parenteral drug delivery.
BACKGROUND OF THE INVENTION
[002] Drug delivery devices in the form of infusers are known in the art for administering medication to a patient. The infusers are intended for mounting on a patient's skin for self-administration of a medication. The activation of the infuser not only provides the injection of a needle into a patient's skin, but also causes the plunger to self-activate in order to direct a medication to the patient through the injection needle. The typical constructions of an infuser have the needle attached to the reservoir. For example, with reference to United States Patent No. 5,858,001 to Tsals et al., An infuser is shown which is activated by rotating displacement of a reservoir containment body. The needle is attached to the device by Tsals et al. which is also penetrated into the skin of a patient by rotating the body. The needle is attached to the body in order to move with it. Other types of infusers are known, including those using standard syringe drums mounted on the needle. With infusers, the ability to independently control needle injection from the administration of a drug is limited.
SUMMARY OF THE INVENTION
[003] The present invention provides a drug delivery device for the injection of a drug, which includes: a tubular reservoir for accommodating a drug; a stopper slidably arranged in the reservoir; a spring for moving the stopper from a first position to a second position in the reservoir; at least one needle, the needle having
Petition 870190112825, of 11/04/2019, p. 14/61
2/21 a distal end for insertion into a patient, and a lumen that extends proximally from the distal end, the lumen being in direct or indirect communication with the reservoir; a needle driver for moving the needle from a first state to a second state; and, an actuator. Activating the actuator causes the spring to move the stopper from the first position to the second position, and the needle driver moves the needle from the first state to the second state. The needle moves with respect to, and separately from, the reservoir, with the needle being moved from the first state to the second state. Advantageously, with the present invention, a drug delivery device is provided, in which a needle moves with respect to the reservoir when it is moved for injection. This allows control of the needle travel separately from the reservoir.
[004] As used in this document, the term distal and its derivatives refers to a direction for a patient during use. The term proximal and its derivatives refer to an outward direction of a patient during use.
[005] These and other characteristics will be better understood by studying the detailed description that follows and the attached drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[006] Figure 1 is a perspective view of a drug delivery device formed in accordance with the present invention;
Figure 2 is a perspective view of a drug delivery device formed in accordance with the present invention with its internal components being shown;
Figure 3 is a rear perspective view of a drug delivery device formed in accordance with the present invention;
Figures 4 to 14 show the different states of a needle driver usable with the present invention;
Petition 870190112825, of 11/04/2019, p. 15/61
3/21
Figures 15 to 19 show the different configurations of a drug delivery device formed in accordance with the present invention;
Figures 20 and 21 show an actuator arrangement usable with the present invention;
Figures 22 and 23 show different sealing arrangements usable with the present invention;
Figures 24 to 26 show a sealing arrangement with a secondary needle usable with the present invention;
Figures 27 and 28 show a method of loading a drug delivery device formed in accordance with the present invention;
Figures 29 to 33 show an alternative method of loading a drug delivery device formed in accordance with the present invention;
Figures 34 to 36 and 40 show an end of dose indicator usable with the present invention;
Figures 37 to 39 show a mechanism for performing a needle retraction usable with the present invention;
Figures 41 to 43 show a releasable button mechanism for retracting the needle that can be used with the present invention;
Figure 44 is a rear perspective view showing a drug delivery device during use, formed in accordance with the present invention, and,
Figures 45 to 47 show a safety pen and a needle protector, both of which can be used with the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[007] With reference to the figures, a drug delivery device designated with the reference numeral 10 is shown. The drug delivery device 10 generally includes a body 12 that accommodates a reservoir 14,
Petition 870190112825, of 11/04/2019, p. 16/61
4/21 at least one needle 16, a needle driver 18, and an actuator 20. The drug delivery device 10 is for the injection of drugs or medication, these terms being used interchangeably herein, in a patient and is particularly well suited to be mounted on a patient's skin for self-administration, as shown below. Any form of medicament, for example, liquid or slurry, including one or more pharmaceutically active agents, can be administered by the drug delivery device 10, as will be recognized by those skilled in the art.
[008] The body 12 includes a housing 22 which comprises a closed volume 24. The closed volume 24 is preferably dimensioned and configured so as to accommodate the working components of the infuser 10 so that they are completely contained within it. The housing 22 is preferably made of a thermoplastic material, but it can be made of other polymeric and / or metallic materials. To facilitate manufacturing, housing 22 may be formed from one or more components that fit together or are otherwise assembled together. One or more openings can be formed in the housing 22 for different purposes. For example, one or more windows 26 can be provided and positioned to allow visual observation of the reservoir 14. In addition, one or more access openings 28 can be provided to allow access to a component, such as the actuator 20. The housing 22 may further include one or more removable panels 30, which also allow access to the interior of the housing 22 in such a way as to allow the filling of the reservoir 14.
[009] The body 12 can be of several formats. As shown in the figures, the body 12 may have a generally rectangular box shape. Other ways are possible. It is preferable that the body 12 includes a generally flat skin mounting surface 32 on which an adhesive 34 is preferably disposed. The adhesive 34 can be of any type that allows the infuser 10 to be mounted on the
Petition 870190112825, of 11/04/2019, p. 17/61
5/21 a patient's skin for use and subsequent removal. Adhesive 34 can be a low pressure pressure sensitive adhesive, however other forms can also be used. An access opening 28 'is formed so as to extend through the housing 22 on the skin mounting surface 32 and is formed so as to allow passage through the needle 16, as described below. Preferably, the adhesive 34 limits the needle access opening 28 '.
[010] Reservoir 14 is preferably a tubular drum. Reservoir 14 is preferably of a circular cross section, but can have other shapes of cross section. In addition, it is preferred that the reservoir 14 is made of glass, but it can also be made of a polymeric material. In a tubular configuration, the reservoir 14 includes a wall 36 that extends between the first and second ends 38, 40, with a lumen 42 that extends between them. A stopper 44 is slidably arranged in the reservoir 14 particularly in a sealing fit with the wall 36 within the lumen 42. The stopper 44 is preferably of an elastomeric material and is formed in any manner known in the art.
[011] At least one needle 16 is mounted on needle driver 18. Reference should be made in this document to the use of a single needle, however, as will be recognized by those skilled in the art, a plurality of needles may be used also used. Needle driver 18 is configured to move needle 16 from a first state to a second state. The first state can coincide with needle 14, more particularly, with the distal end 46 of needle 14, which is contained within body 12 (Figure 4). The second state can coincide with the distal end 46 of the needle 16 which is exposed externally to the body 12 so as to be in an injection position (Figure 6). Needle 16 and distal end 46 can be formed in any manner known for injection into a patient.
Petition 870190112825, of 11/04/2019, p. 18/61
6/21
[012] The needle 16 includes a lumen 48 that extends proximally from the distal end 46. The lumen 48 is in direct or indirect communication with the reservoir 14. In direct communication, an open passage is defined between the reservoir 14 and the lumen 48. More preferably, a breakable sealing or adjustable valve arrangement is in the flow path between reservoir 14 and lumen 48 so as to allow selective communication between them. With this arrangement, the inadvertent flow from the reservoir 14 and through the lumen 48 can be minimized, particularly during transport and storage.
[013] In a preferred arrangement, a flow channel 50 extends from lumen 48 and through needle driver 18 for communication with reservoir 14. In a preferred arrangement, needle driver 18 is in the form of an arm in deformable cantilever, having a fixed end 52 and a free end 54. The needle 16 is fixed at or near the free end 54, using any known technique. Preferably, the needle driver 18 is made of a thermoplastic material, with the needle 16 being made of a metallic material. The needle 16 can be adhered and / or molded on the needle driver 18. The flow channel 50 is defined so as to extend through the needle driver 18 for communication with the lumen 48.
[014] The needle driver 18 can be of various configurations that allow the displacement of the needle 16. The needle driver 18 is forced to move under a driving force that can be generated from the internal resilience of the needle driver 18 or applied from an external source, such as a spring or other force applicator. With reference to Figure 4, it is preferred that the needle driver 18 is in a flat, non-polarized state prior to use. In this way, plastic deformation of the needle driver 18 to an unwanted state can be avoided. It is possible to make the free end 54 of the
Petition 870190112825, of 11/04/2019, p. 19/61
7/21 needle 18 remains in a deflected state, in which the internal resilience of the needle driver 18 can provide an elastic force for the displacement of the needle 16. Any form of retention mechanism can be used to reliably retain the driver needle 18 in the deflected state. However, maintaining the needle driver 18 in the deflected state may result in plastic deformation thereof with little or no spring return after releasing the retaining mechanism. Although the needle driver 18 can be configured to overcome the situation by choosing the material, it is preferred that the needle driver 18 is made generally flat, so as not to provide a deflected, or otherwise deformed state .
[015] The drug delivery device 10 is configured in such a way that, after activation, the drug is self-directed from the reservoir 14 and, separately, the needle 16 moves so as to be inserted into the patient. It is preferred that a single actuation of the actuator 20 is made in order to obtain this double effect. Various actuator configurations can be used. As a non-limiting example, the actuator 20 can be a type of displaceable button that is configured for linear displacement. As will be appreciated by those skilled in the art, other actuators can be used.
[016] A spring 58 is provided for the movement of the stopper 44 from a first position to a second position in the reservoir 14. The movement of the stopper 44 causes the medicine to move from the reservoir 14. In an initial use, a retention arrangement is provided in order to keep the stopper 44 in the first position against the force of the spring 58. After actuation of the actuator 20, the retention arrangement is released, thus allowing the movement of the stopper 44 towards the second position. At the same time, the actuation of the actuator 20 causes the needle driver 18 to move the needle 16 so that it is injected into a patient. The medicine, under the force of the movement of the stopper 44, is forced to flow through the
Petition 870190112825, of 11/04/2019, p. 20/61
8/21 needle 16 so as to be administered to a patient.
[017] The actuation of the needle driver 18 can be done in several ways. In a preferred embodiment, an elongated, gutter-shaped needle actuator 60 may alternatively be provided coextensive with at least a portion of the needle driver 18. One or more tabs 62 extend from the needle driver 18 so running along the tracks or other accessories formed on the needle actuator 60. In a preferred arrangement, the needle actuator 60 is forced to move linearly with respect to the needle actuator 18, causing the tongues 62 to move along the needle actuator accessories 60. This interaction results in needle displacement 16.
[018] In a preferred embodiment, two sets of tabs 62 are provided, that is, a set of spring tabs 62a and a set of release tabs 62b. The release tabs 62b are positioned at or near the free end 54 of the needle driver 18. The spring tabs 62a are located in an intermediate position of the needle driver 18 between the fixed end 52 and the free end 54. It is preferred that the spring tabs 62a and the release tabs 62b are shaped and configured so as to provide a collective actuation force that is uniformly applied to the needle driver 18. The generation of a moment on the longitudinal geometric axis 64 is undesirable.
[019] As shown in Figures 4 and 12, and shown above, the needle driver 18 is preferably initially in a generally flat state before use. With actuation of the actuator 20, the needle actuator 60 is forced to move relative to the needle actuator 18 in such a way that the inclined surfaces 66 cause a downward deflection of the spring tabs 62a, as shown in Figure 13 In this state, the release tabs 62b engage with the locking surfaces 68. Due to the interconnection between the release tabs 62b and the locking surfaces 68, the deflection of the ex
Petition 870190112825, of 11/04/2019, p. 21/61
9/21 free tremor 54 is prevented. With sufficient movement of the needle actuator 60 with respect to the needle actuator 18, the release tabs 62b are forced away from the locking surfaces 68. The displacement of the spring tabs 62a generates an elastic force in the needle actuator 18, which causes the free end 54 to be forced back to its flat, natural state, with the free end 54 moving downward (Figure 14). This set of successive actions causes the needle 16 to move from the first state, shown in Figure 12, to the second state, shown in Figure 14. As shown above, in the first state, the needle 16, in particular its end distal 46, is inside the inner volume 24, whereas, in the second state, the distal end 46 is exposed externally to the envelope 22. The displacement of needle 16 is done to cause needle 16 to penetrate a patient's skin to injection.
[020] Once moved, the needle driver 18 seeks to recover its initial flat configuration through the inherent memory of its constituent material. As shown in Figure 14, the interconnection between the angled surfaces 66 and the spring tabs 62a keeps the needle 16 in the second state, penetrated into a patient.
[021] As will be appreciated by those skilled in the art, other arrangements for carrying out needle displacement 16 can be used. For example, a releasable spring arrangement can be used, whereby the needle driver 18 is retained in the first state against the spring force, with the release of a retaining arrangement that allows the spring force to displace the driver needle 18 for the second state. The spring force can be supplied by several types of springs, such as compression springs, helical springs, elastomeric elements, gas compression springs, and so on.
[022] The movement of the needle actuator 60 with respect to the
Petition 870190112825, of 11/04/2019, p. 22/61
10/21 needle 18 can be provided in different configurations. Preferably, a needle actuator spring 70 is provided so as to act against the needle actuator 60 in order to cause its displacement.
[023] Various retaining arrangements can be provided in order to keep the needle actuator 60 in a first state against the force of the needle actuator spring 70 before use, as shown in Figure 4. Preferably, the arrangement retainer is released by working the actuator 20. As a non-limiting example, and with reference to Figures 4 to 6, the retaining arrangement may include a protrusion 72 that extends from the needle actuator 60 so as to be fitted by actuator 20. A lock channel 74 is defined in the projection 72 on which a lock flange 76 is seated in an initial pre-use state. With the displacement of the actuator 20, after the actuation, the lock flange 76 comes out of the socket with the lock channel 74, as shown in Figure 5. The lock flange 76 can be defined by a portion of the actuator 20. The needle actuator 60 then moves under the force of the needle actuator spring 70.
[024] The stroke of the needle actuator 60 can be limited by interlocking a lock or similar element. A gap opening 78 (Figure 2) is formed in needle actuator 60 through which needle 16 passes after displacement. The gap opening 78 is at least partial with the needle access opening 28 'during the displacement of the needle 16 in order to allow the needle 16 to perform an injection in a patient (Figure 44). The needle access opening 28 'is sized and configured so as not to interfere with needle 16 during injection.
[025] The gap opening 78 can be configured to limit the travel of the needle driver 18 during an actuation. In particular, the gap opening 78 can be configured to allow the needle 16 to pass through it, but not the needle driver 18. Therefore, the interconnection between the
Petition 870190112825, of 11/04/2019, p. 23/61
11/21 the needle actuator 18 and the portions of the needle actuator 60 adjacent to the gap opening 78 act as a limit to the displacement of the needle actuator 18. This defines the second state of the needle actuator 18 and can define the injection depth of the needle 16. Alternatively, the gap opening 78 can be configured so that it does not undesirably fit the needle driver 18. In this way, the patient's skin acts as a lock for the needle driver 18.
[026] With respect to the movement of the stopper 44, a retention arrangement can be provided in order to restrict the movement of the stopper 44 against the force of the spring 58 in an initial, pre-use state. As a non-limiting example, and with reference to Figures 20 and 21, a plunger 80 can be provided, which is in engagement with the stopper 44 and is formed so as to extend to become attachable by the actuator 20. A plunger locking channel 82 can be formed on plunger 80, and a plunger locking flange 84 can be provided formed so as to rest on plunger locking channel 82 in an initial, pre-used state. With the displacement of the actuator 20, after actuation, the plunger lock flange 84 moves so as to disengage from the plunger lock channel 82, thus allowing the displacement of the stopper 44 under the movement force of the spring 58. The plunger lock flange 84 can be defined by a portion of the actuator 20. As will be appreciated by those skilled in the art, a single actuation of the actuator 20 may result in the release of both stopper 44 and needle actuator 60. For example , with reference to Figure 21, the actuator 20 can define both the locking flange 76 and the plunger locking flange 84, such that the displacement of the actuator 20 results in the displacement of the locking flange 26 and the locking flange of plunger 84 with simultaneous release of both stopper 44 and needle actuator 60.
[027] With drug delivery device 10 intended for use against a patient's skin, it is preferred that reservoir ventilation 14 or
Petition 870190112825, of 11/04/2019, p. 24/61
12/21 the action of the needle 16 is not necessary for the administration of the medication from the reservoir 14.
[028] With the needle 16 to be inserted in a patient, and the stopper 44 moving, the medicine can be moved from the reservoir 14 through the flow channel 50 and administered to a patient through the needle 16, when there is direct communication between the lumen 42 of the needle 16 and the reservoir 14. As indicated above, it is preferred that a breakable seal arrangement or adjustable valve is used in order to provide an indirect communication, with the communication being obtained by breaking the sealing and / or valve adjustment arrangement.
[029] In a preferred embodiment, an adjustable valve 86 can be used. Referring to Figure 22, valve 86 includes a valve stem 88 provided with one or more sealing elements 90. In a variation, as shown in Figure 22, sealing elements 90 can be configured to seal a portion of reservoir 14 in an initial state. In this way, the medicine contained inside the reservoir 14 can be contained, during transport and storage, inside the reservoir 14. It is preferred that the reservoir 14 has a small diameter neck portion 92 at the first end 38 that defines the opening of outlet 94. It is preferred that valve 86 seals the reservoir 14 so as to contain the medicament entirely within it. In this way, the stability of the drug in the reservoir 14, in particular, during storage, can be better maintained. As indicated above, it is preferred that the reservoir 14 is made of glass.
[030] In a preferred arrangement, as shown in Figure 23, an adapter 96 can be provided, on which the first end 38 of the reservoir 14 is seated. The first end 38 of the reservoir 14 can be formed in the same manner as a standard syringe tip, for example, a Luer tip. a
Petition 870190112825, of 11/04/2019, p. 25/61
13/21 flow space 98 is provided on adapter 96 adjacent to, and in communication with, reservoir 14. Sealing elements 90 are configured, in this arrangement, to seal flow space 98 in order to prevent flow from the same. With this arrangement, however, the medicament may come into contact with parts of the adapter 96, in particular the portions of the adapter 96 on the flow space 98 prior to use (for example, during transport and storage). Adapter 96 may be made of plastic or other polymeric material. The choice of materials for valve 86 and adapter 96 should be considered taking into account the medication to be stored in the reservoir 14.
[031] In order to make a flow from the reservoir 14, the valve 86 is made adjustable, in order to adjust from a sealed state, of pre-use, to an open state, of use. Referring to Figure 22, in the alternative embodiment, the neck portion 92 preferably includes an inwardly extending lip 100 defined over the outlet opening 94. In the initial state, as shown in Figure 22, the seal 90 seals against lip 100 in order to seal flow space 98 from reservoir 14. In order to reach the open state, valve 86 moves in such a way that valve stem 88 moves into the reservoir 14 with the sealing elements 90 exiting the sealing fitting with the lip 100. Therefore, a flow path is therefore defined on the valve stem 88 and through the outlet opening 94. Flow channel 50 may thus, to enter in communication with the flow space 98. With the valve 86 being in the open state, and with the stopper 44 moving, the medicine is propelled from the reservoir 14 through the outlet opening 94, into the space flow 98, and into channel d and flow 50 for administration to a patient. In order to provide a seal of the flow space 98, the adapter 96 may be provided with an elevated seal ring 102 which comes in close contact with the valve stem 88. In addition, or alternatively, secondary sealing elements
Petition 870190112825, of 11/04/2019, p. 26/61
14/21
104 can be provided on the valve 86 formed to define a seal with portions of the adapter 96 in order to further restrict the flow through it.
[032] In the preferred embodiment, shown in Figure 23, valve 86 can be adapted to form a seal in a similar manner, in this case causing the sealing elements 90 to fit against and form a seal with the O-ring. sealing 102 of adapter 96. Adjusting valve 86 in the direction of reservoir 14 causes sealing elements 90 to disengage from sealing ring 102 so as to allow flow through it. The flow channel 50 can be in communication with a secondary flow space 116, and the sealing ring 102 can be positioned between the secondary flow space 16 and a flow space 98. The secondary sealing elements 104 are provided so to seal the secondary flow space 16 and prevent inadvertent flow from it.
[033] Adjustment of valve 86 can be achieved in several ways. In a preferred embodiment, a pivot valve oscillator 106 can be used. As shown in Figures 2 and 8, valve oscillator 106 is mounted on a pivot pin 108 so as to become pivotable thereon. A first arm 110 of valve oscillator 106 extends from pivot pin 108 to engage with valve 86. A second arm 112 of valve oscillator 106 extends in an opposite direction from the pivot pin 108 so as to engage with needle actuator 60. As shown in Figure 9, valve oscillator 106 is configured to engage with needle actuator 60 in sufficient motion relative to the needle actuator 18. With sufficient movement of the needle actuator 60, the second arm 112 is forced to move, resulting in the pivot movement of the valve oscillator 106 and the corresponding movement of the first arm 110 against the valve 86. The movement against
Petition 870190112825, of 11/04/2019, p. 27/61
15/21 the valve 86 results in its adjustment from the sealed state to the open state. More particularly, the movement of valve 86 results in displacement of valve stem 88 towards or in the direction of reservoir 14.
[034] As shown in Figure 22, valve 86 may include a locking ring or tooth 114 for a releasable retention of valve 86 in the sealed state. Locking ring 114 is shaped so that it resiliently detaches from adapter 96 under sufficient movement force from valve oscillator 106. Locking ring 114 acts to prevent inadvertent adjustment of valve 86 before use.
[035] As will be appreciated by those skilled in the art, reservoir 14 can be of various configurations. Preferably, a syringe barrel can be used to define the reservoir 14, especially when the neck portion 92 is used. It is still preferred to use the sealing arrangement of Figure 23, in which a standard syringe can be used without any modification. Reservoir 14 can be drum-shaped, with one end being selectively sealed by valve 86. Alternatively, as shown in Figures 8 to 10 and 24 to 26, a secondary stopper 118 or a septum 120 can be used in the direction to seal the first end 38 of the reservoir 14. In this case, the reservoir 14 can be in the form of a medicine cartridge with the septum 120 sealing the outlet opening 94 which is defined in the neck portion 92 (Figure 25). The septum 120 can be made of any elastomeric material, as is known in the art, that allows a perforation through it, as described below. Alternatively, the reservoir 14 can include the secondary stop 118 which is positioned at or near the first end 38, away from the stop 44 (Figure 8). The secondary stop 118 can be arranged in the lumen 48 to form a seal against the reservoir 14, as is known in the art.
[036] With the use of secondary stopper 118 or septum 120, an access can be provided to the contents of reservoir 14 through the use of a needle if
Petition 870190112825, of 11/04/2019, p. 28/61
16/21 secondary 122 (Figures 24 to 26). The secondary needle 122 includes a first end 124 initially spaced from or partially embedded in the secondary stop 118 or septum 120. With a relative movement between the secondary needle 122 and the reservoir 14, the first end 124 of the secondary needle 122 is able to pierce the secondary stop 18 or septum 120 in order to gain access to the contents inside the reservoir 14. Any way of obtaining a relative movement can be used. In a preferred arrangement, with the reservoir 14 being sealed by the secondary stop 118 or by the septum 120, the reservoir 14 can be forced to move under the force of the action of the spring 58 before the first end 124 of the secondary needle 122 pierces the stopper secondary 118 or septum 120. In a totally sealed state, and with the drug being a liquid or a slurry, the drug becomes generally incompressible, with a force being transmitted through it to allow movement of the entire the reservoir 14. With the secondary needle 122 accessing the contents of the reservoir 14, the greater force applied to the stopper 44 by the spring 58 will cause the medication to be pushed into the lumen 126 of the secondary needle 122 for administration to a patient. Secondary needle 122 is formed with a second end 127 in communication with flow channel 50.
[037] In order to limit the inadvertent movement of the reservoir 14, one or more lock fingers 128 may extend from the housing 22 or other adjacent components in order to undesirably involve the reservoir 14 in a limiting movement of the same . With sufficient force being applied to the reservoir 14, the one or more locking fingers 128 can be forced to deform or dislodge to allow movement of the reservoir 14. Secondary needle 122 can be attached to housing 22 in any way known. In addition, secondary needle 122 can be curved or otherwise configured to allow lumen 126 to contact flow channel 50.
Petition 870190112825, of 11/04/2019, p. 29/61
17/21
[038] With the use of the secondary needle 122, the second end 127 can be formed so as to extend into the needle driver 18 with the lumen 126 in communication with the flow channel 50 (Figure 24). With the actuation of the needle driver 18, the needle driver 18 can rotate on the secondary needle 122 and, at the same time, maintain communication with it. When the secondary needle 122 is not used, the driver 18 can be provided with an extension 17 through which the flow channel 50 extends for communication with the reservoir 14 (directly or indirectly) (Figure 2).
[039] Drug delivery device 10 can be pre-assembled and stored with the drug in reservoir 14 prior to transport and storage. With reference to Figures 27 and 28, the drug delivery device 10 can be prepared with the reservoir 14 which is in a partially assembled state inside the housing 22 and filled in that state. Therefore, as shown in Figures 27 and 28, the reservoir 14 can be filled through the second end 40 through one of the access openings 28. Once filled, the stopper 44 can be inserted into the lumen 48 of the reservoir 14 a in order to seal the reservoir 14 and the drug delivery device 10 can be completely assembled. Referring to Figure 15, the reservoir 14 can be pre-assembled and pre-filled with medicine and then mounted on the housing 22 with one of the access openings 28. In order to facilitate manufacturing, one or more components of the delivery device of drug 10 can be shaped as a module, and in this way, for example, plunger 80 can be provided together with spring 58 and actuator 20. Module housing 130 can be provided to accommodate components in a mounted state.
[040] In an alternative arrangement, and with reference to Figures 29 to 33, the reservoir 14 can be maintained separately from the drug delivery device 10 prior to use. For example, reservoir 14 may be in the form of a car
Petition 870190112825, of 11/04/2019, p. 30/61
18/21 medicine tube. As shown in Figure 29, the window 26 can be shaped and configured to allow the reservoir 14 to pass through it so as to position itself inside the housing 22. This movement is similar to the insertion of a battery in a device. One or more locking retaining elements 132 can be provided in order to couple the reservoir 14 and in order to provide a retention for it in a desired position. In the desired position, the stopper 44 is positioned to align with the plunger 80, and the outlet opening 94 is positioned to align with the secondary needle 122, to allow it to be pierced. Reservoir 14 can be in the form of a drum of constant diameter, with stopper 44 and septum 120 with reservoir 14 being inserted through window 26 in the same manner as described above, with reservoir 14 being in the form of a cartridge of medicine.
[041] As will be appreciated by those skilled in the art, the drug delivery device 10 may include accessories other than those described above. For example, it may be desired to provide retraction of needle 16 after use. Needle 16 can be forced to retract in several ways. Referring to Figures 37 to 39, in one approach, the needle actuator 60 is forced to move in an opposite direction with respect to the needle driver 18, this direction being opposite to the original movement direction performed to cause the needle to move 16. As a non-limiting example, as shown in Figures 37 to 39, the actuation spring 134 can be arranged inside the piston 80, which is arranged to act against the secondary piston 136. The piston secondary 136 is kept in an initial position due to the interconnection with a lock 138. As soon as the stopper 44 reaches the end of its full stroke, the latch 138 is released, causing the secondary piston 136 to be pushed forward under the force of the actuation spring 134. Secondary piston 136 fits against valve 86, applying one over it in order to move valve 86 and cause
Petition 870190112825, of 11/04/2019, p. 31/61
19/21 it returns to its initial state. The valve 86 thus acts against the valve oscillator 106, with a consequent reverse movement of rotation in the direction of its original state. In response, valve oscillator 106 acts against needle actuator 60 in order to propel needle actuator 60 to its original state. With the movement of the needle actuator 60 to its original state, the displacement of the needle actuator 18 is reversed and the needle 16 is forced to retract.
[042] In a preferred embodiment, as shown in Figures 41 to 43, the first arm 110 of the valve oscillator 106 can be curved or otherwise configured to define a lock 140, positioned to fit the actuator needle 60 over a predetermined range of motion with respect to needle driver 18. Latch 140 is positioned to allow sufficient movement of needle actuator 60 to allow needle 16 to be moved for injection. The secondary actuator 142, which is preferably in the form of a linearly displaceable button, is positioned so as to press against the latch 140 in order to disengage the needle actuator 60. With the disengagement, the needle actuator 60 is free to move forward under the force of the needle actuation spring 70 (Figure 42). The secondary inclined surfaces 144 are positioned to engage against the release tabs 62b so as to cause the needle 16 to retract into the housing 22 (Figure 7). In addition, as shown in Figure 40, this movement of the needle actuator 60 causes the gap opening 78 to come out of alignment with the needle access opening 28 ', which further limits access to the needle 16 .
[043] The drug delivery device 10 may further be provided with an end-of-dose indicator in order to provide a sensory indication that the dose has been fully administered. Referring to Figures 34 to 36 and 40, the plunger 80 can be provided with an indicator sleeve 146 which is shaped to fit
Petition 870190112825, of 11/04/2019, p. 32/61
20/21 extend through the stopper 44 in an initial state. The indicator sleeve 146 includes a ridge 148. The plunger 80 is provided with outwardly displaceable engaging elements 150 positioned to restrict the movement of the indicator sleeve 146 out of the stopper 44. With the plunger 80 being moved by the spring 58 in order to propel a medicine from the reservoir 14, the stopper 44 eventually reaches a limit position, with the fitting against a portion of the reservoir 14 and / or against the secondary stopper 118. This position will coincide with the end of the dosing course. As shown in Figure 36, indicator sleeve 146 will be engaged by part of the reservoir 14 and / or by the secondary stopper 118 prior to engagement by the stopper 44. An additional force applied to the stopper 44 by the plunger 80 will cause the displacement of the locking elements 150 along the ridge 148. The plunger 80 is provided with one or more indication windows 152. In the initial state, the indicator sleeve 146 is out of alignment with the indication windows 152. When moved at the end of the dosing stroke, a portion of the indicator sleeve 146 comes into alignment with one or more indicator windows 152 so that it can be visually observable from the outside of the plunger 80 (Figure 40). One or more of the windows 26 of the housing 22 can be aligned so that the indicator sleeve 146 can be seen through the indicator windows 152. Preferably, the indicator sleeve 146 is made in a different color from the plunger 80 in a way to become easily discernible. It should also be noted that the overrunning of the ridge 148 by the locking elements 150 can also provide a tactile and / or audible indication of an end of administration dose.
[044] With reference to Figure 3, it should also be noted that a needle guard 154 can be provided in order to cover the needle access opening 28 ', prior to use. The needle guard 154 can be attached, for example, by means of a friction fit within the needle access opening 28 '. One finger flap 156
Petition 870190112825, of 11/04/2019, p. 33/61
21/21 can be provided to extend from the needle guard 154, in particular beyond the perimeter of the wrapper 22 to facilitate removal of the needle guard 154.
[045] A safety pin 158 can also be provided and formed in order to act in conjunction with actuator 20 in order to avoid inadvertent actuation. With reference to Figures 45 to 47, the safety pin 158 can be shaped so that it extends into the actuator 20 in order to prevent its displacement. The safety pin 158 needs to be removed in order to allow the actuator 56 to act. The safety pin 158 can be formed in a unitary manner with the needle guard 154 such that, with a single removal of the needle guard assembly 154 and safety pin 158, the drug delivery device 10 can be prepared for ready use.

权利要求:
Claims (12)
[1]
1. Drug delivery device (10) for the injection of a drug, said drug delivery device (10) comprising:
- a tubular reservoir for accommodating a medicament, said reservoir extending along a longitudinal geometric axis (64);
- a stopper (44) slidably arranged in said reservoir;
- a spring (58) for moving said stopper (44) from a first position to a second position in said reservoir;
- at least one needle (16), said needle (16) having a distal end (46) for insertion in a patient, and a lumen (48) extending proximally from said distal end (46), said lumen (48) being in direct or indirect communication with said reservoir, in which at least a portion of said lumen (48) extending proximally from said distal end (46) extends along a geometric axis of non-coaxial reference to said longitudinal geometric axis (64);
- a needle driver (18) for moving said needle (16) in a direction transverse to said longitudinal geometric axis (64) from a first state to a second state; and,
- an actuator, in which the activation of said actuator causes:
- said spring (58) moves said stopper (44) from said first position to said second position; and,
- said needle driver (18) moves said needle (16) from said first state to said second state, CHARACTERIZED by the fact that
- said needle (16) moves in relation to, and separately from, said reservoir, with said needle (16) being moved from said first state to said second state, said needle driver (18) moving said needle (16) from said first state and to said second state under force applied to
Petition 870190112825, of 11/04/2019, p. 35/61
[2]
2/3 an intermediate location of said needle driver (18) between its ends (52, 54), and said needle driver (18) includes a cantilever arm (110, 112), the deformation of said cantilever arm (110, 112) causing said needle (16) to move from said first state and to said second state.
2. Drug delivery device (10) according to claim
1, CHARACTERIZED by the fact that it further comprises a flow channel (50) in communication with said lumen (48) of said needle (16), said flow channel (50) being selectively communicable with said reservoir, and in which , in an initial state, said flow channel (50) is not in communication with said reservoir.
[3]
3. Drug delivery device (10) according to claim
2, CHARACTERIZED by the fact that the activation of said actuator causes said channel (50) to communicate with said reservoir.
[4]
4. Drug delivery device (10) according to claim 2, CHARACTERIZED by the fact that it also comprises an adjustable valve (86) in order to allow a selective communication between said flow channel (50) and said reservoir .
[5]
5. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that it also comprises a second stopper (44) disposed in said reservoir and spaced from said stopper (44).
[6]
6. Drug delivery device (10) according to claim 5, CHARACTERIZED in that it further comprises at least one secondary needle (16) having a lumen (48) in communication with said flow passage, said needle secondary (16) having a proximal end, wherein, in an initial state, said proximal end of said secondary needle (16) is spaced from, or partially embedded in, said second stopper (44), and, wherein said second stopper (44) is movable so as to be pierced through it by said needle
Petition 870190112825, of 11/04/2019, p. 36/61
3/3 secondary (16) so as to allow said proximal end of said secondary needle (16) to be in communication with said reservoir.
[7]
7. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that it also includes an adhesive to adhere the infuser adherently to a patient.
[8]
8. Drug delivery device (10) according to claim 1, CHARACTERIZED by the fact that said needle driver (18) further includes a spring (58) in order to cause deformation of said cantilevered arm ( 110, 112).
[9]
9. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that it further comprises an indicator to indicate that said stopper (44) has moved to said second position.
[10]
10. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that it also comprises a body in which said reservoir is accommodated, in which a window is formed in said body to allow visualization of at least a portion of said reservoir.
[11]
11. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that it also comprises a body in which said reservoir is accommodated, in which, in said first state, said distal end (46) of said needle (16) is within said body, and, in said second state, said distal end (46) of said needle (16) is exposed externally to said body.
[12]
12. Drug delivery device (10), according to claim 1, CHARACTERIZED by the fact that said reference geometric axis is not parallel to said longitudinal geometric axis (64).

类似技术:

公开号 | 公开日 | 专利标题

BR112012029642B1|2020-05-26|DRUG ADMINISTRATION DEVICE

JP6685232B2|2020-04-22|Drug device

AU2019264517B2|2021-05-06|Drug delivery device

AU2014200306B2|2015-04-02|Drug delivery device

BR112016012539B1|2021-11-30|APPARATUS FOR PRODUCING A STERILE CONNECTION, MEDICAL DEVICE AND METHOD FOR CREATING A STERILE CONNECTION WITH A FLUID IN A CONTAINER

同族专利:

公开号 | 公开日

ES2571331T3|2016-05-24|

JP2013526366A|2013-06-24|

CN104984438A|2015-10-21|

CA2799721A1|2011-11-24|

EP3527241A1|2019-08-21|

EP3824924A1|2021-05-26|

SG10202001055YA|2020-04-29|

DK3520841T3|2021-06-07|

US20170049958A1|2017-02-23|

EP3028726A1|2016-06-08|

EP3824925A1|2021-05-26|

US10478552B2|2019-11-19|

SG10201700716VA|2017-02-27|

EP2571549B1|2016-02-24|

EP3520841B1|2021-03-10|

CA2935653A1|2011-11-24|

SG10201503939SA|2015-07-30|

JP6454751B2|2019-01-16|

US20130110049A1|2013-05-02|

EP2571549A1|2013-03-27|

EP3028726B1|2019-05-01|

AU2011256804A1|2013-01-10|

CN104984438B|2018-08-10|

BR112012029642A2|2017-07-04|

US11202857B2|2021-12-21|

CA2935653C|2019-12-24|

MX369242B|2019-11-01|

JP2017176843A|2017-10-05|

MX2019012969A|2019-12-16|

US9408985B2|2016-08-09|

US20200330679A1|2020-10-22|

JP5934188B2|2016-06-15|

ES2859665T3|2021-10-04|

DK3527241T3|2021-03-08|

AU2011256804B2|2013-10-17|

EP3527241B1|2020-12-23|

MX2019009490A|2019-11-05|

DK3028726T3|2019-07-29|

ES2737175T3|2020-01-10|

ES2867031T3|2021-10-20|

MX2019009478A|2019-11-05|

SG10201700715SA|2017-02-27|

US20210178057A1|2021-06-17|

CN102971027B|2015-08-26|

CA2799721C|2016-09-06|

JP6141400B2|2017-06-07|

EP3520841A1|2019-08-07|

SG185653A1|2012-12-28|

CN102971027A|2013-03-13|

US20200009317A1|2020-01-09|

MX2012013426A|2013-02-12|

WO2011146166A1|2011-11-24|

JP2016073722A|2016-05-12|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

RU2179864C2|1993-07-31|2002-02-27|Вестон Медикал Лимитед|Needleless injector|

CA2231542A1|1995-09-11|1997-03-20|Elan Medical Technologies Limited|Medicament delivery device|

US5858001A|1995-12-11|1999-01-12|Elan Medical Technologies Limited|Cartridge-based drug delivery device|

US6500150B1|1997-06-16|2002-12-31|Elan Pharma International Limited|Pre-filled drug-delivery device and method of manufacture and assembly of same|

US5957895A|1998-02-20|1999-09-28|Becton Dickinson And Company|Low-profile automatic injection device with self-emptying reservoir|

EP1064035B1|1998-03-23|2003-11-26|ELAN CORPORATION, Plc|Drug delivery device|

US20030109827A1|2001-12-07|2003-06-12|Elan Pharma International Limited|Drug delivery system and method|

US20040010207A1|2002-07-15|2004-01-15|Flaherty J. Christopher|Self-contained, automatic transcutaneous physiologic sensing system|

AU2003296884B2|2002-07-22|2009-07-16|Becton, Dickinson And Company|Patch-like infusion device|

US20040049129A1|2002-09-05|2004-03-11|Yan Qi|Wafer assembly having a resilient extendable/retractable needle means for healthcare|

EP1545661A2|2002-09-12|2005-06-29|Children's Hospital Medical Center|Method and device for painless injection of medication|

CA2520995A1|2003-04-07|2004-10-21|Atl Engineering Limited|An infinitely variable continuous recliner mechanism for vehicle seats and similar applications|

EP1475113A1|2003-05-08|2004-11-10|Novo Nordisk A/S|External needle inserter|

AT474611T|2003-05-08|2010-08-15|Novo Nordisk As|A SKIN-INJECTABLE INJECTION DEVICE WITH A SEPARATE ACTUATING PART FOR INTRODUCING THE NEEDLE|

AT457761T|2003-05-08|2010-03-15|Novo Nordisk As|TILTABLE DEVICE FOR AN INJECTION NEEDLE|

EP1495775A1|2003-07-08|2005-01-12|Novo Nordisk A/S|Portable drug delivery device having an encapsulated needle|

US7635348B2|2003-11-04|2009-12-22|Meridian Medical Technologies, Inc.|Container for medicament automatic injector and automatic injector adapted therefor|

US20080097291A1|2006-08-23|2008-04-24|Hanson Ian B|Infusion pumps and methods and delivery devices and methods with same|

US7789857B2|2006-08-23|2010-09-07|Medtronic Minimed, Inc.|Infusion medium delivery system, device and method with needle inserter and needle inserter device and method|

CA2691356C|2007-06-12|2015-04-28|Becton, Dickinson And Company|Syringe with disabling mechanism|

CN101909674B|2007-11-12|2013-04-10|邦奥鲁夫森梅迪康股份有限公司|Auto injector with automatic needle retraction|

MX2010014258A|2008-07-07|2011-03-21|Unomedical As|Inserter for transcutaneous device.|

DK2337596T3|2008-09-18|2020-02-10|Becton Dickinson Co|Medical injector with garbage stamp|

EP2419161B1|2009-04-15|2016-06-01|Becton Dickinson and Company|Fixturing member and device for permitting mixing in a pen injector|

EP2451386B1|2009-07-10|2015-08-19|Kirk Promotion LTD.|Implantable medical device for lubricating an artificial contacting surface|

EP2459267B1|2009-07-31|2017-12-20|3M Innovative Properties Company|Hollow microneedle arrays|

JP5650241B2|2009-12-16|2015-01-07|ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ，ＤｉｃｋｉｎｓｏｎＡｎｄＣｏｍｐａｎｙ|Self injection device|

ES2867031T3|2010-05-20|2021-10-20|Becton Dickinson Co|Drug delivery device|US9656019B2|2007-10-02|2017-05-23|Medimop Medical Projects Ltd.|Apparatuses for securing components of a drug delivery system during transport and methods of using same|

US9345836B2|2007-10-02|2016-05-24|Medimop Medical Projects Ltd.|Disengagement resistant telescoping assembly and unidirectional method of assembly for such|

US10420880B2|2007-10-02|2019-09-24|West Pharma. Services IL, Ltd.|Key for securing components of a drug delivery system during assembly and/or transport and methods of using same|

US20090093793A1|2007-10-02|2009-04-09|Yossi Gross|External drug pump|

MX2010012691A|2008-05-20|2011-03-30|Avant Medical Corp Star|Autoinjector system.|

US9393369B2|2008-09-15|2016-07-19|Medimop Medical Projects Ltd.|Stabilized pen injector|

US8157769B2|2009-09-15|2012-04-17|Medimop Medical Projects Ltd.|Cartridge insertion assembly for drug delivery system|

US7967795B1|2010-01-19|2011-06-28|Lamodel Ltd.|Cartridge interface assembly with driving plunger|

US8348898B2|2010-01-19|2013-01-08|Medimop Medical Projects Ltd.|Automatic needle for drug pump|

WO2011141907A1|2010-05-10|2011-11-17|Medimop Medical Projects Ltd.|Low volume accurate injector|

ES2867031T3|2010-05-20|2021-10-20|Becton Dickinson Co|Drug delivery device|

US8905972B2|2010-11-20|2014-12-09|Perqflo, Llc|Infusion pumps|

DK2699293T3|2011-04-20|2019-04-29|Amgen Inc|AUTO INJECTION DEVICE|

US9707335B2|2011-09-02|2017-07-18|Unitract Syringe Pty Ltd|Drive mechanism for drug delivery pumps with integrated status indication|

CA2845367C|2011-09-02|2019-09-17|Unitract Syringe Pty Ltd|Drive mechanism for drug delivery pumps with integrated status indication|

US11173244B2|2011-09-02|2021-11-16|Unl Holdings Llc|Drive mechanism for drug delivery pumps with integrated status indication|

US9814832B2|2011-09-02|2017-11-14|Unl Holdings Llc|Drive mechanism for drug delivery pumps with integrated status indication|

CN103957962B|2011-10-05|2017-07-07|犹诺医药有限公司|Insert for inserting multiple percutaneous parts simultaneously|

EP2583715A1|2011-10-19|2013-04-24|Unomedical A/S|Infusion tube system and method for manufacture|

IN2014CN03380A|2011-11-07|2015-10-09|Safety Syringes Inc|

US9072827B2|2012-03-26|2015-07-07|Medimop Medical Projects Ltd.|Fail safe point protector for needle safety flap|

DK2836252T3|2012-04-13|2018-01-15|Becton Dickinson Co|Micro infusion device with automatic needle retraction|

US10071196B2|2012-05-15|2018-09-11|West Pharma. Services IL, Ltd.|Method for selectively powering a battery-operated drug-delivery device and device therefor|

IL221634D0|2012-08-26|2012-12-31|Medimop Medical Projects Ltd|Universal drug vial adapter|

DK2890431T3|2012-08-29|2017-04-03|Unitract Syringe Pty Ltd|DRIVE MANAGEMENTS WITH CONTROLLED DELIVERY TO PHARMACEUTICAL DELIVERY PUMPS|

US10071198B2|2012-11-02|2018-09-11|West Pharma. Servicees IL, Ltd.|Adhesive structure for medical device|

US9421323B2|2013-01-03|2016-08-23|Medimop Medical Projects Ltd.|Door and doorstop for portable one use drug delivery apparatus|

CA2898639A1|2013-01-25|2014-07-31|Unitract Syringe Pty Ltd|Drive mechanism for drug delivery pumps with integrated status indication|

US9011164B2|2013-04-30|2015-04-21|Medimop Medical Projects Ltd.|Clip contact for easy installation of printed circuit board PCB|

AU2014259600B2|2013-05-03|2018-12-20|Becton, Dickinson And Company|Flow pathway subassembly|

JP6691041B2|2013-06-18|2020-04-28|イネイブルインジェクションズ、インコーポレイテッド|Vial transfer and injection devices and methods|

GB2578705B|2013-08-07|2020-11-11|West Pharmaceutical Services Il Ltd|Liquid transfer devices for use with infusion liquid containers|

DK3041527T3|2013-09-05|2018-08-13|Sanofi Aventis Deutschland|DRIVING DEVICE MECHANISM INSTALLATION DEVICE|

EP3041548B1|2013-09-05|2018-12-19|Sanofi-Aventis Deutschland GmbH|Drive mechanism for a needle insertion arrangement|

MX2016007050A|2013-12-01|2017-05-25|Becton Dickinson Co|Medicament device.|

JP2015128480A|2014-01-06|2015-07-16|大研医器株式会社|Controlling devices controlling infusion set and drive thereof, and infusion set with liquid medicine feeding function having controlling devices|

US10220147B2|2015-08-13|2019-03-05|Windgap Medical, Inc.|Mixing and injection device with sterility features|

US10159786B2|2014-09-30|2018-12-25|Perqflo, Llc|Hybrid ambulatory infusion pumps|

EP3217944B1|2015-01-05|2019-04-10|West Pharma. Services IL, Ltd|Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage|

US9795534B2|2015-03-04|2017-10-24|Medimop Medical Projects Ltd.|Compliant coupling assembly for cartridge coupling of a drug delivery device|

US10182969B2|2015-03-10|2019-01-22|Regeneron Pharmaceuticals, Inc.|Aseptic piercing system and method|

US10293120B2|2015-04-10|2019-05-21|West Pharma. Services IL, Ltd.|Redundant injection device status indication|

US10149943B2|2015-05-29|2018-12-11|West Pharma. Services IL, Ltd.|Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly|

WO2016196934A1|2015-06-04|2016-12-08|Medimop Medical Projects Ltd.|Cartridge insertion for drug delivery device|

CN107921214B|2015-07-02|2021-03-02|西兰制药公司|Needle control and drug mixing system for fluid delivery device|

US10357429B2|2015-07-16|2019-07-23|West Pharma. Services IL, Ltd.|Liquid drug transfer devices for secure telescopic snap fit on injection vials|

CN107029317B|2015-07-31|2020-07-28|重庆倍加医疗器械有限公司|Medicine injector|

US9987432B2|2015-09-22|2018-06-05|West Pharma. Services IL, Ltd.|Rotation resistant friction adapter for plunger driver of drug delivery device|

US10086145B2|2015-09-22|2018-10-02|West Pharma Services Il, Ltd.|Rotation resistant friction adapter for plunger driver of drug delivery device|

WO2017090042A1|2015-11-25|2017-06-01|Medimop Medical Projects Ltd|Dual vial adapter assemblage including drug vial adapter with self-sealing access valve|

EP3711793B1|2016-01-21|2021-12-01|West Pharma Services IL, Ltd.|A method of connecting a cartridge to an automatic injector|

AU2017218443A1|2016-02-12|2018-08-30|Medtronic Minimed, Inc.|Ambulatory infusion pumps and assemblies for use with same|

US10376647B2|2016-03-18|2019-08-13|West Pharma. Services IL, Ltd.|Anti-rotation mechanism for telescopic screw assembly|

IL245803D0|2016-05-24|2016-08-31|West Pharma Services Il Ltd|Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter|

IL245800D0|2016-05-24|2016-08-31|West Pharma Services Il Ltd|Dual vial adapter assemblages including identical twin vial adapters|

CN109310831B|2016-06-02|2021-11-23|西医药服务以色列有限公司|Three position needle retraction|

IL246073D0|2016-06-06|2016-08-31|West Pharma Services Il Ltd|Fluid transfer devices for use with drug pump cartridge having slidable driving plunger|

EP3496783B1|2016-08-12|2020-12-02|Sanofi-Aventis Deutschland GmbH|Medicament delivery device|

IL247376D0|2016-08-21|2016-12-29|Medimop Medical Projects Ltd|Syringe assembly|

WO2018073424A2|2016-10-21|2018-04-26|Sanofi-Aventis Deutschland Gmbh|Liquid medicament administration device|

GB2556633A|2016-11-18|2018-06-06|Owen Mumford Ltd|Medicament delivery device|

IL249408D0|2016-12-06|2017-03-30|Medimop Medical Projects Ltd|Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom|

IL251458D0|2017-03-29|2017-06-29|Medimop Medical Projects Ltd|User actuated liquid drug transfer devices for use in ready-to-useliquid drug transfer assemblages|

US11260171B2|2017-07-04|2022-03-01|Medtronic Minimed, Inc.|Ambulatory infusion pumps and assemblies for use with same|

CN107362402B|2017-08-07|2020-08-21|广东省人民医院|Single-cylinder automatic radiography injector|

WO2019079181A1|2017-10-16|2019-04-25|Becton, Dickinson And Company|End-of-dose detection for drug delivery system|

CN111372631A|2017-10-16|2020-07-03|贝克顿·迪金森公司|Connector for aseptically transferring fluids|

JP1630477S|2018-07-06|2019-05-07|

JP1648075S|2019-01-17|2019-12-16|

法律状态:
2019-01-08| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|

2019-08-06| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

2020-03-31| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

2020-05-26| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/03/2011, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

申请号 | 申请日 | 专利标题

US34654210P| true| 2010-05-20|2010-05-20|

US61/346.542|2010-05-20|

PCT/US2011/030182|WO2011146166A1|2010-05-20|2011-03-28|Drug delivery device|

[返回顶部]